These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 27761605)
1. Primary neurolymphomatosis as clinical onset of chronic lymphocytic leukemia. Briani C; Visentin A; Cavallaro T; Cacciavillani M; Cabrini I; Ferrari S; Zambello R; Trentin L Ann Hematol; 2017 Jan; 96(1):159-161. PubMed ID: 27761605 [No Abstract] [Full Text] [Related]
2. Early Direct Antiglobulin Test Negativity after Bendamustine and Rituximab Treatment in Chronic Lymphocytic Leukemia: Two Cases. Eren R; Suyanı E Turk J Haematol; 2018 Nov; 35(4):312-313. PubMed ID: 29983407 [No Abstract] [Full Text] [Related]
3. Bilateral acute orbital compartment syndrome secondary to Richter syndrome: the 'tulip' sign. Stewart CM; McDonald B; Clifford R; Norris JH Clin Exp Ophthalmol; 2016 Nov; 44(8):722-724. PubMed ID: 27061968 [No Abstract] [Full Text] [Related]
4. What is the status of novel anti-CD20 antibodies for chronic lymphocytic leukemia and are they set to leave rituximab in the shadows? Chaudhry M; Cheson BD Expert Rev Hematol; 2015 Dec; 8(6):733-42. PubMed ID: 26368831 [TBL] [Abstract][Full Text] [Related]
6. Obinutuzumab (GA101) is highly effective against chronic lymphocytic leukemia cells in ex vivo B-cell depletion irrespective of high-risk prognostic markers. Ysebaert L; Laprévotte E; Klein C; Quillet-Mary A Blood Cancer J; 2015 Nov; 5(11):e367. PubMed ID: 26565404 [No Abstract] [Full Text] [Related]
7. Small lymphocytic lymphoma presenting as bulky renal incidentaloma. Kamachi K; Kojima K; Nishijima A; Takeshita M; Ando T; Kimura S Int J Hematol; 2014 Aug; 100(2):107-8. PubMed ID: 24928522 [No Abstract] [Full Text] [Related]
8. The reactivation of occult HBV infection emerging with the case of acute hepatitis B in the wife of a subject treated with rituximab-based chemotherapy. Macera M; Capoluongo N; Gambardella M; Starace M; Minichini C; Pisaturo M; Pasquale G; Coppola N Antivir Ther; 2015; 20(3):349-52. PubMed ID: 25105989 [TBL] [Abstract][Full Text] [Related]
9. Chronic lymphocytic leukemia in a patient with sickle cell anemia. Kim HS; Yospur L; Niihara Y West J Med; 1998 Aug; 169(2):114-6. PubMed ID: 9735696 [No Abstract] [Full Text] [Related]
10. Chronic lymphocytic leukemia. Johnson LE Am Fam Physician; 1988 Dec; 38(6):167-76. PubMed ID: 3057841 [No Abstract] [Full Text] [Related]
12. Dasatinib-induced response in a rare case of chronic lymphocytic leukaemia associated with chronic myeloid leukaemia. Tecchio C; Nichele I; Todeschini G; Pizzolo G; Ambrosetti A Br J Haematol; 2009 Jul; 146(2):222-3. PubMed ID: 19466973 [No Abstract] [Full Text] [Related]
13. Neurolymphomatosis: a case series of clinical manifestations, treatments, and outcomes. Kamiya-Matsuoka C; Shroff S; Gildersleeve K; Hormozdi B; Manning JT; Woodman KH J Neurol Sci; 2014 Aug; 343(1-2):144-8. PubMed ID: 24928074 [TBL] [Abstract][Full Text] [Related]
14. Rapid resolution of Mycobacterium marinum chronic skin infection during lenalidomide therapy for chronic lymphocytic leukemia. Awais A; Tam CS; Kontoyiannis D; Ferrajoli A; Duvic M; Cortes J; Keating MJ Clin Infect Dis; 2008 Apr; 46(7):e69-71. PubMed ID: 18444808 [TBL] [Abstract][Full Text] [Related]
15. Fulminant B hepatitis in a surface antigen-negative patient with B-cell chronic lymphocytic leukaemia after rituximab therapy. Niscola P; Del Principe MI; Maurillo L; Venditti A; Buccisano F; Piccioni D; Amadori S; Del Poeta G Leukemia; 2005 Oct; 19(10):1840-1. PubMed ID: 16094417 [No Abstract] [Full Text] [Related]
16. An unusual manifestation in a patient with Neurofibromatosis type 1. Miraglia E; Iacovino C; Cantisani C; Calvieri S; Giustini S G Ital Dermatol Venereol; 2016 Feb; 151(1):129-30. PubMed ID: 26924035 [No Abstract] [Full Text] [Related]
17. Anti-CD20 monoclonal antibody rituximab for the treatment of B-cell chronic lymphocytic leukemia-associated pure red cell aplasia. Pantelidou D; Tsatalas C; Margaritis D; Kaloutsi V; Spanoudakis E; Bourikas G Hematol J; 2004; 5(6):546-7. PubMed ID: 15570303 [No Abstract] [Full Text] [Related]
18. Alemtuzumab as first-line therapy for B-cell chronic lymphocytic leukemia: long-term follow-up of clinical effects, infectious complications and risk of Richter transformation. Karlsson C; Norin S; Kimby E; Sander B; Porwit Macdonald A; Nilsson B; Johansson E; Mellstedt H; Lundin J; Osterborg A Leukemia; 2006 Dec; 20(12):2204-7. PubMed ID: 17051245 [No Abstract] [Full Text] [Related]
19. Severe anemia caused by combination of autoimmune hemolysis, pure red cell aplasia and massive bone marrow infiltration in an elderly patient with chronic lymphocytic leukemia: successful treatment with rituximab. Smolej L; Belada D; Cermanová M; Maisnar V; Lunáková E Leuk Res; 2010 May; 34(5):e140-1. PubMed ID: 20053448 [No Abstract] [Full Text] [Related]
20. Ofatumumab in rituximab-refractory autoimmune hemolytic anemia associated with chronic lymphocytic leukemia: a case report and review of literature. Nader K; Patel M; Ferber A Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):511-3. PubMed ID: 23726016 [No Abstract] [Full Text] [Related] [Next] [New Search]